The Holder of Common Stock Purchase Warrants of InMed Pharmaceuticals Inc. issued February 12, 2021Purchase Agreement and Common Stock Purchase Warrant • March 22nd, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMarch 22nd, 2022 Company IndustryInMed Pharmaceuticals Inc. (the “Company”) desires to amend (i) the Securities Purchase Agreement, dated as of February 5, 2021, by and among the Company and the purchasers signatory thereto pursuant to which the Company issued, among other securities, the Warrants (as defined below) (the “Purchase Agreement”) and (ii) the Common Stock Purchase Warrant issued February 12, 2021, by the Company and the purchaser(s) signatory thereto pursuant to which the Company issued the Warrants (as defined below) (the “Warrant Agreement”).
The Holder of Common Stock Purchase Warrants of Statera Biopharma, Inc. issued February 9, 2022Purchase Agreement and Common Stock Purchase Warrant • March 22nd, 2022 • Statera Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 22nd, 2022 Company IndustryStatera Biopharma Inc. (the “Company”) desires to amend (i) the Securities Purchase Agreement, dated as of February 6, 2022, by and among the Company and the purchaser signatory thereto pursuant to which the Company issued, among other securities, the Warrants (as defined below) (the “Purchase Agreement”) and (ii) the Common Stock Purchase Warrant issued February 9, 2022, by the Company and the purchaser signatory thereto pursuant to which the Company issued the Warrants (as defined below) (the “Warrant Agreement”).